Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

First Generic Epipen Approved

Aschenbrenner, Diane S. MS, RN

AJN The American Journal of Nursing: December 2018 - Volume 118 - Issue 12 - p 23–24
doi: 10.1097/01.NAJ.0000549688.51382.a8
Drug Watch
Buy
  • The Food and Drug Administration has granted Teva Pharmaceuticals approval to market the first generic version of the EpiPen.
  • Some of the controversies surrounding approval of this generic product are described below. Alternatives to the EpiPen are also highlighted.

Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.